| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4002544 | American Journal of Ophthalmology | 2013 | 10 Pages |
Abstract
A single intraocular injection of 0.4 mg MP0112 resulted in levels above the half-maximal inhibitory concentration and neutralization of VEGF in aqueous humor for 8-12 weeks. Despite inflammation in several patients, there was prolonged edema reduction and improvement in vision in several patients. The source of the inflammation was eliminated from a new preparation that is being tested in an ongoing clinical trial.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Peter A. Campochiaro, Roomasa Channa, Brian B. Berger, Jeffrey S. Heier, David M. Brown, Ulrike Fiedler, Julia Hepp, Michael T. Stumpp,